AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
96,100
Employees96,100
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
96,100
Employees96,100

AZN Key Statistics

Market cap
318.45B
Market cap318.45B
Price-Earnings ratio
31.05
Price-Earnings ratio31.05
Dividend yield
1.54%
Dividend yield1.54%
Average volume
1.74M
Average volume1.74M
High today
$205.30
High today$205.30
Low today
$200.98
Low today$200.98
Open price
$202.98
Open price$202.98
Volume
1.14M
Volume1.14M
52 Week high
$212.71
52 Week high$212.71
52 Week low
$132.32
52 Week low$132.32

Stock Snapshot

AstraZeneca(AZN) stock is priced at $204.97, giving the company a market capitalization of 318.45B. It carries a P/E multiple of 31.05 and pays a dividend yield of 1.5%.

On 2026-04-18, AstraZeneca(AZN) stock traded between a low of $200.98 and a high of $205.30. Shares are currently priced at $204.97, which is +2.0% above the low and -0.2% below the high.

AstraZeneca(AZN) shares are trading with a volume of 1.14M, against a daily average of 1.74M.

During the past year, AstraZeneca(AZN) stock moved between $132.32 at its lowest and $212.71 at its peak.

During the past year, AstraZeneca(AZN) stock moved between $132.32 at its lowest and $212.71 at its peak.

AZN News

TipRanks 2h
AstraZeneca’s Danicopan Korea Study: Real-World Data That Could Shape AZN’s Rare Disease Edge

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...

TipRanks 2d
AstraZeneca Nears Key COPD Milestone With Phase III Tozorakimab Trial

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisio...

TipRanks 4d
AstraZeneca Targets Early Detection in China With New ATTR Heart Disease Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
9.7%
Sell
9.7%

More AZN News

TipRanks 4d
AstraZeneca Completes Early Imaging Study in Crohn’s Disease, Nudging Pipeline Hopes for AZN

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisio...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.
Pfizer
Moderna
Disney
Delta Air Lines
Bank of America
Gilead Sciences

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.